FDA approves first spray on skin treatment for burns
Treating third degree burns today often involves skin grafts and more pain for the patient, spray on skin will put an end to that misery.
Key takeaways
- In the US alone, roughly half a million people have to seek medical treatment for their burns each year.
- ReCell is the creation of AVITA Medical, a global regenerative medicine company.
- Perry told media outlets that ReCell reduces the amount of healthy skin that gets damaged during a skin graft by 97 percent for a second degree burn, and even more for a third degree burn.
Cite or link to this article
Griffin, M. (2018) 'FDA approves first spray on skin treatment for burns', 311 Institute, 5 October. Available at: https://www.311institute.com/fda-approves-first-spray-on-skin-treatment-for-burns/ (Accessed: 1 October 2026).
Over the past couple of years we’ve gotten increasingly good at 3D printing human skin and making artificial skin that, for example, can be used to create next generation prosthetics and robots that can “feel,” and now there’s even more good news, especially for the millions of people who suffer severe burns and abrasions every year. ReCell, a skin cell solution, which is one of several revolutionary “spray on skin” regenerative medicine products, is the first treatment of its kind approved by the US Food and Drug Administration for growing back skin.
In the US alone, roughly half a million people have to seek medical treatment for their burns each year. The most traditional form of treatment for bad burns comes in the form of skin grafts. However, those require more pain on the part of the patient, as doctors have to cut away and remove healthy skin elsewhere on the body to cover the burns.
ReCell is the creation of AVITA Medical, a global regenerative medicine company. According to CEO Michael Perry, the company wanted to give burn patients more treatment options - especially ones that were less painful.
“Today’s approval of the ReCell System marks an important milestone for us and provides a new way to treat burns for the thousands of patients with significant unmet medical needs, said Perry in a statement.
“We are grateful to those patients who participated in clinical trials of the RECELL System and to the clinical trial investigator teams whose dedication and scientific rigor made this approval possible. We also greatly appreciate our collaboration with BARDA and the support that they have provided to us throughout the development of the RECELL System.”
ReCell is definitely not the only solution that’s been in the works over the past years though, it’s just the first one to get the magical FDA stamp of approval which means they can now sell it to healthcare providers throughout the US.
In 2009, MIT researchers made headlines when they proposed a similar spray-on skin solution, and elsewhere RenovaCare also created the SkinGun which I talked about a little while ago.
However, Avita’s technology beat its competitors to FDA approval, and possibly to the market, first.
ReCell reduces how much skin has to be removed over the burned surface before treatment, the company explained. It uses enzymes to break down those layers of skin from a piece of tissue. It then mixes those tissue cells into a liquid that’s applied to the skin using a simple, low-tech spray.
In most burn scenarios, skin grafts can require more skin than a patient anticipates. There’s also nerve damage along with damaging skin and muscle tissues.
Perry told media outlets that ReCell reduces the amount of healthy skin that gets damaged during a skin graft by 97 percent for a second degree burn, and even more for a third degree burn.
For doctors, ReCell could give them a new way to treat patients faster, easier, and safer than ever before. It takes just 30 minutes to process a patient’s skin, and because it’s the patient’s own skin from the area, there’s next to no possibility of rejection.
“Today’s approval of the RECELL System is a significant advancement in how we treat patients with burns,” said James H Holmes IV, MD, FACS, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina. “Dramatically reducing the amount of donor skin needed to treat second and third degree burns has important implications for pain, scarring and costs of care, while still providing comparable healing to the current standard of care. Additionally, the potential reduction in mortality is extremely promising.”
Currently, AVITA hasn’t listed a price for ReCell. However, Perry told NBC News it could be between $5,000 to $10,000 per unit. That cost would cover roughly 10 percent of a patient’s body. Deeper burns or burns covering a larger surface area would naturally require more units.
Source: AVITA
FAQ
Why does this matter?
Treating third degree burns today often involves skin grafts and more pain for the patient, spray on skin will put an end to that misery.

About the author
Matthew Griffin Founder, 311 Institute
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."
Read full bio
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.
An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.
As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.
Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.
What future do you need to see?
Choose one to get started on biotech and enhanced humans and the future of your organisation.
Sources and further reading
- US Food and Drug Administration fda.gov
- AVITA Medical, avitamedical.com
- Avita medical announces fda approval of the recell system for the treatment of severe burns in the u s biospace.com
- Fda approves first spray skin product n911976 nbcnews.com
Source: first published by the 311 Institute on 5 October 2018. Cite as: Griffin, M. (2018). FDA approves first spray on skin treatment for burns. 311 Institute. https://www.311institute.com/fda-approves-first-spray-on-skin-treatment-for-burns/
You are welcome to quote this article with credit and a link to the original.